<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03651713</url>
  </required_header>
  <id_info>
    <org_study_id>201807752</org_study_id>
    <nct_id>NCT03651713</nct_id>
  </id_info>
  <brief_title>Hyperglycemia, Exercise, and Endothelial Function</brief_title>
  <official_title>Effect of Short-Term Glucose Loading on Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine if exercise preserves vascular function during
      hyperglycemia. All subjects will consume a sugary beverage three times daily for seven days.
      Subjects will be randomly assigned to either the glucose with (GLU+EX) or without (GLU)
      structured exercise group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute (oral glucose tolerance test) and chronic (type 2 diabetes) hyperglycemia are
      associated with impaired endothelial function. Both a single bout of exercise and chronic
      exercise training are associated with improvements in vascular endothelial function. It
      remains unknown if exercise can preserve vascular endothelial function during hyperglycemia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Actual">October 21, 2019</completion_date>
  <primary_completion_date type="Actual">October 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Vascular Endothelial Function</measure>
    <time_frame>Before and after the seven-day intervention in both groups.</time_frame>
    <description>Brachial artery flow-mediated dilation (%), measured via Doppler ultrasound, will be assessed before and after the intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central Blood Pressure</measure>
    <time_frame>Before and after the seven-day intervention in both groups.</time_frame>
    <description>Aortic blood pressure will be derived from radial artery pressure wave measurements (via applanation tonometry) during resting conditions.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Physical Activity</measure>
    <time_frame>Continuously throughout the seven-day intervention.</time_frame>
    <description>Steps per day will be recorded via accelerometry throughout the intervention in both groups.</description>
  </other_outcome>
  <other_outcome>
    <measure>Caloric Consumption</measure>
    <time_frame>Continuously throughout the seven-day intervention.</time_frame>
    <description>Subjects will record their dietary intake throughout the intervention.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Endothelial Function</condition>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>GLU+EX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume a 75g glucose beverage three times daily for seven days while participating in five structured aerobic exercise sessions throughout the experimental protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GLU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will consume a 75g glucose beverage three times daily for seven days without participating in structured aerobic exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>GLU+EX</intervention_name>
    <description>Subjects will complete 45 minutes of recumbent cycling at 60-65% of age-predicted maximal heart rate five times over seven days while ingesting a 75g glucose beverage three times daily.</description>
    <arm_group_label>GLU+EX</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>GLU</intervention_name>
    <description>Subjects will consume a 75g glucose beverage three times daily over a seven-day period.</description>
    <arm_group_label>GLU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Healthy young men 18-35 years of age.

        Exclusion Criteria:

          -  Hypertension,

          -  Hyperlipidemia,

          -  Smoking,

          -  Heart disease,

          -  Chest pain upon exertion,

          -  Previous heart surgeries or history of arrhythmias,

          -  Diabetes,

          -  Obesity (body mass index ≥30kg/m2),

          -  Kidney disease,

          -  Pulmonary disease,

          -  Autonomic disorders,

          -  Individuals whom engage in structured exercise (≥30min, ≥2d/wk),

          -  Current use of medications which influence outcome measures
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical Education Building</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 22, 2018</study_first_submitted>
  <study_first_submitted_qc>August 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Darren P Casey</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>exercise</keyword>
  <keyword>glucose</keyword>
  <keyword>vascular function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

